Meeting of the National Advisory Council for Healthcare Research and Quality, 12561-12562 [2020-04293]
Download as PDF
<![CDATA[
12561
Federal Register / Vol. 85, No. 42 / Tuesday, March 3, 2020 / Notices
PICOS (POPULATIONS, INTERVENTIONS, COMPARATORS, OUTCOMES, SETTINGS, STUDY DESIGN SETTINGS)—Continued
PICOS
Inclusion criteria
Exclusion criteria
Outcomes ........................................
Patient Health Outcomes (highest priority) ...........................................
• Mortality/survival.
Æ To arrival at hospital.
Æ To hospital discharge.
Æ Any period less than or equal to 30 days post-injury.
• Morbidity.
Æ Glasgow Outcome Scale, Glasgow Outcome Scale Extended,
Modified Rankin Scale, Cerebral Performance Category.
Æ Pneumothorax.
Æ Aspiration pneumonia.
• Length of Stay.
Æ Hospital length of stay (days).
Æ ICU length of stay (days).
Æ ICU-free days.
Intermediate Outcomes (secondary priority).
• Overall success rate.
• First pass success rate.
• Number of prehospital attempts to secure an airway.
• EtCO2 values.
• Effective oxygenation.
• Effective ventilation.
• Definitive Airway Sans Hypoxia/Hypotension on First Attempt
(DASH–1A).
Adverse Events/Harms.
• Vomiting.
• Gastric content aspiration.
• Hypoxia (SpO2<90%).
• Hyperventilation (EtCO2<35).
• Hypoventilation (EtCO2>45).
• Hypotension.
• Oral trauma, airway trauma.
• Barotrauma.
• Misplaced tube.
• Need for additional airway interventions.
• Prehospital .........................................................................................
• ED only if needed to fill important gaps where there are no
prehospital studies.
• International studies in English language.
Long-term outcomes (more than
30 days post-injury).
Setting .............................................
Study Design ...................................
• RCTs ..................................................................................................
If RCTs do not provide sufficient evidence, the following designs will
be included:
• Prospective comparative studies.
• Retrospective comparative studies.
• Case control studies.
Airway studies conducted in cadaver labs, or simulated environments; operating rooms; or
inpatient.
ED
studies
if
prehospital studies of the topic
are available.
• Systematic reviews (we will use
reference lists to identify studies
for possible inclusion).
• Case series.
• Descriptive studies.
• Letters to the editor.
• Opinion papers.
• Studies published prior to 1990.
BiPAP = bilevel positive airway pressure; CPAP = continuous positive airway pressure; DSI = delayed sequence intubation; ED = emergency
department; ICU = intensive care unit; KQ = Key Question; RCT = randomized controlled trial; RSI = rapid sequence intubation
Dated: 26 February 2020.
Virginia L. Mackay-Smith,
Associate Director, Office of the Director,
AHRQ.
[FR Doc. 2020–04253 Filed 3–2–20; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
lotter on DSKBCFDHB2PROD with NOTICES
AGENCY:
This notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality.
SUMMARY:
VerDate Sep<11>2014
17:19 Mar 02, 2020
Jkt 250001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
The meeting will be held on
Thursday, March 26, 2020, from 8:30
a.m. to 2:45 p.m.
DATES:
The meeting will be held at
AHRQ, 5600 Fishers Lane, Rockville,
Maryland 20857.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A,
Rockville, Maryland 20857, (301) 427–
1456. For press-related information,
please contact Bruce Seeman at (301)
427–1998 or Bruce.Seeman@
AHRQ.hhs.gov.
E:\FR\FM\03MRN1.SGM
03MRN1
12562
Federal Register / Vol. 85, No. 42 / Tuesday, March 3, 2020 / Notices
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
Thursday, March 12, 2020. The agenda,
roster, and minutes will be available
from Ms. Heather Phelps, Committee
Management Officer, Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Rockville, Maryland
20857. Ms. Phelps’ phone number is
(301) 427–1128.
Dated: February 26, 2020.
Virginia L. Mackay-Smith,
Associate Director.
SUPPLEMENTARY INFORMATION:
AGENCY:
In accordance with section 10(a) of
the Federal Advisory Committee Act, 5
U.S.C. App., this notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality (the Council). The Council is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
(B) the field of health care research
including training needs and
information dissemination on health
care quality, and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
lotter on DSKBCFDHB2PROD with NOTICES
II. Agenda
On Thursday, March 26, 2020, the
Council meeting will convene at 8:30
a.m., with the call to order by the
Council Chair and approval of previous
Council summary notes. The meeting is
open to the public and will be available
via webcast at
www.webconferences.com/ahrq. The
meeting will begin with an update on
AHRQ’s recent accomplishments and
budget. The agenda will also include a
discussion about 21st Century Care,
AHRQ’s Digital Healthcare Research
Agenda, and Synthetic Data. The
meeting will adjourn at 2:45 p.m. The
final agenda will be available on the
AHRQ website at www.AHRQ.gov no
later than Thursday, March 19, 2020.
17:19 Mar 02, 2020
Jkt 250001
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
I. Purpose
VerDate Sep<11>2014
[FR Doc. 2020–04293 Filed 3–2–20; 8:45 am]
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project ‘‘AHRQ
Research Reporting System (ARRS).’’
DATES: Comments on this notice must be
received by 60 days after date of
publication.
SUMMARY:
Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
email at doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
Proposed Project
AHRQ Research Reporting System
(ARRS)
AHRQ has developed a systematic
method for its grantees and vendors to
report project progress and important
preliminary findings for grants and
contracts funded by the Agency. This
system, the AHRQ Research Reporting
System (ARRS), previously known as
the Grants Reporting System (GRS), was
last approved by OMB on May 22nd,
2017. The system addressed the
shortfalls in the previous reporting
process and established a consistent and
comprehensive grants reporting solution
for AHRQ. The ARRS provides a
centralized repository of grant and
contract research progress and
additional information that can be used
to support initiatives within the Agency.
This includes future research planning
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
and support for administrative activities
such as performance monitoring,
budgeting, knowledge transfer and
strategic planning.
This Project has the following goals:
(1) To promote the transfer of critical
information more frequently and
efficiently and enhance the Agency’s
ability to support research designed to
improve the outcomes and quality of
health care, reduce its costs, and
broaden access to effective services
(2) To increase the efficiency of the
Agency in responding to ad-hoc
information requests
(3) To support Executive Branch
requirements for increased
transparency and public reporting
(4) To establish a consistent approach
throughout the Agency for
information collection regarding grant
and contract progress and a
systematic basis for oversight and for
facilitating potential collaborations
among grantees
(5) To decrease the inconvenience and
burden on grantees and vendors of
unanticipated ad-hoc requests for
information by the Agency in
response to particular (one-time)
internal and external requests for
information
This project is being conducted by
AHRQ pursuant to AHRQ’s statutory
authority to conduct and support
research on healthcare and on systems
for the delivery of such care, including
activities with respect to the quality,
effectiveness, efficiency,
appropriateness and value of healthcare
services and with respect to quality
measurement and improvement. 42
U.S.C. 299a(a)(1) and (2).
Method of Collection
To achieve the goals of this project the
following data collections will be
implemented:
AHRQ Research Reporting System
(ARRS)—Grantees and vendors use the
ARRS system to report project progress
and important preliminary findings for
grants and contracts funded by the
Agency. Grantees and vendors submit
progress reports on a monthly or
quarterly basis which are reviewed by
AHRQ personnel. All users access the
ARRS system through a secure online
interface which requires a user I.D. and
password entered through the ARRS
login screen. When status reports are
due AHRQ notifies principal
investigators and vendors via email.
The ARRS is an automated userfriendly resource that is utilized by
AHRQ staff for preparing, distributing,
and reviewing reporting requests to
grantees and vendors for the purpose of
E:\FR\FM\03MRN1.SGM
03MRN1
]]>Agencies
[Federal Register Volume 85, Number 42 (Tuesday, March 3, 2020)]
[Notices]
[Pages 12561-12562]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04293]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Meeting of the National Advisory Council for Healthcare Research
and Quality
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a meeting of the National Advisory
Council for Healthcare Research and Quality.
DATES: The meeting will be held on Thursday, March 26, 2020, from 8:30
a.m. to 2:45 p.m.
ADDRESSES: The meeting will be held at AHRQ, 5600 Fishers Lane,
Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management
Official, at the Agency for Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427-
1456. For press-related information, please contact Bruce Seeman at
(301) 427-1998 or [email protected].
[[Page 12562]]
If sign language interpretation or other reasonable accommodation
for a disability is needed, please contact the Food and Drug
Administration (FDA) Office of Equal Employment Opportunity and
Diversity Management on (301) 827-4840, no later than Thursday, March
12, 2020. The agenda, roster, and minutes will be available from Ms.
Heather Phelps, Committee Management Officer, Agency for Healthcare
Research and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms.
Phelps' phone number is (301) 427-1128.
SUPPLEMENTARY INFORMATION:
I. Purpose
In accordance with section 10(a) of the Federal Advisory Committee
Act, 5 U.S.C. App., this notice announces a meeting of the National
Advisory Council for Healthcare Research and Quality (the Council). The
Council is authorized by Section 941 of the Public Health Service Act,
42 U.S.C. 299c. In accordance with its statutory mandate, the Council
is to advise the Secretary of the Department of Health and Human
Services and the Director of AHRQ on matters related to AHRQ's conduct
of its mission including providing guidance on (A) priorities for
health care research, (B) the field of health care research including
training needs and information dissemination on health care quality,
and (C) the role of the Agency in light of private sector activity and
opportunities for public private partnerships. The Council is composed
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.
II. Agenda
On Thursday, March 26, 2020, the Council meeting will convene at
8:30 a.m., with the call to order by the Council Chair and approval of
previous Council summary notes. The meeting is open to the public and
will be available via webcast at www.webconferences.com/ahrq. The
meeting will begin with an update on AHRQ's recent accomplishments and
budget. The agenda will also include a discussion about 21st Century
Care, AHRQ's Digital Healthcare Research Agenda, and Synthetic Data.
The meeting will adjourn at 2:45 p.m. The final agenda will be
available on the AHRQ website at www.AHRQ.gov no later than Thursday,
March 19, 2020.
Dated: February 26, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-04293 Filed 3-2-20; 8:45 am]
BILLING CODE 4160-90-P
